Funding for this research was provided by:
Deyang Science and Technology Bureau, Project name: Exploring the application value of iron death related gene GCLC in renal papillary cell carcinoma (Project Number: 2023SZZ015)
Article History
Received: 15 May 2024
Accepted: 9 July 2024
First Online: 16 August 2024
Declarations
:
: The authors declare that there are no conflicts of interest regarding the publication of this paper.
: This study is approved by the Ethics Committee of People’s Hospital of Deyang City.
: Due to the retrospective nature of the study, informed consent was waived.